On August 20, Li Qiang, member of the Standing Committee of the Political Bureau of the CPC Central Committee and Premier of the State Council, undertook a study on the biomedicine industry in Beijing. He underscored the importance of bolstering technological provision and policy backing to drive the enhancement and upgradation of the industry, aiming to develop more high-quality and efficient medications that contribute to the health and well-being of the populace.
